United States
Self-motivated and experienced in elucidating late-phase Hematology and Oncology drug mechanism, generating reliable data that aids clinical trials, and understanding disease pathogenesis. I am a charismatic presenter with a strong experience in written and verbal communication that educates key stake holders, colleagues, and thought leaders. My previous experiences demonstrate a strong ability to drive progress and create a sturdy support for my team. Proactive - Communicator - Innovator - Team player I will love to share more with you, let's connect! E-mail: [email protected]
Written communication as evidenced by strong contributions to preclinical and clinical (biomarker, phase 3b) study reports and manuscripts. Plan and participate in medical meetings to drive asset strategies, tactical plan execution and educate stakeholders (commercial team and medical science liaisons) on key focus areas. Strong collaborative skills as evidenced vendor engagements for conference plannings and to create proactive and reactive decks for educational purposes. Experienced in using 3rd party software (Aperture & Prism by Komodo Health) to gather vital information about HCP and asset usage across healthcare organizations. Collaboratively planned and executed studies designed to assess a new indication for a late phase oncology drug resulting in patent filing, conference presentations (ASH & EHA) and a new clinical study arm. Skilled at design and execution of preclinical translational research approaches to understand drug mechanisms and identifying ideal patient population for best efficacy and precision medicine efforts. Effectively manage diverse responsibilities such as internal and external STEM events and employee outreach to improve and increase employee engagement activities.
Collaboratively planned and individually executed studies designed to assess a new indication for a late phase oncology drug, which resulted in patent filing and will potentially broaden a clinical study. Effectively manage diverse responsibilities within the team by ensuring adequate progression of research projects and liaising with Environmental & Health Safety team to ensure compliance with company and external regulations. Deep commitment to fostering Patient support and engagement by volunteering as part of Global Patient Week committee, which showcased team and company dedication to patients around the globe.
Guest lecturer: "Targeted protein degradation: drugging the undruggable"
Investigate the role of redox-active cysteines in mediating the catalysis of soluble guanylyl cyclase, an enzyme that helps prevent hypertension. Techniques: DNA isolation, cDNA generation, primer design, electrophoresis, Protein expression, purification and analysis. Cell culture (insect, bacteria and mammalian) & harvesting, IEX with FPLC, AE, IMAC, Cellular assays (ELISA, radio-active assay, Biotin-switch, UV-vis), Fluorescence spectrophotomter, SDS-PAGE, Western Blot, Immunofluorescence, Immunoprecipitation, Mutagenesis, Vector design, PCR, siRNA, shRNA, small molecule inhibitors, dose-response studies, Cellular transfection and infection.